Therapeutically reeducating macrophages to treat GBM.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 24100977.
- Also identified by DOI 10.1038/nm.3355.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Glioblastoma multiforme (GBM) is the most common type of aggressive malignant brain cancer. The current lack of successful therapeutics means that this disease has a dismal prognosis. However, a new study in mice offers hope for patients with GBM by demonstrating the efficacy of a novel drug that targets GBM-associated macrophages (pages 1264–1272).
Medical subject headings
- Brain Neoplasms
- Glioblastoma
- Macrophages
- Receptor, Macrophage Colony-Stimulating Factor